We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Countdown to Cognizant (CTSH) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS
Read MoreHide Full Article
Wall Street analysts expect Cognizant (CTSH - Free Report) to post quarterly earnings of $1.11 per share in its upcoming report, which indicates no change from the year-ago quarter. Revenues are expected to be $4.72 billion, down 1.9% from the year-ago quarter.
The current level reflects a downward revision of 0.3% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
Bearing this in mind, let's now explore the average estimates of specific Cognizant metrics that are commonly monitored and projected by Wall Street analysts.
The combined assessment of analysts suggests that 'Revenue- Financial services' will likely reach $1.38 billion. The estimate indicates a year-over-year change of -6.8%.
The average prediction of analysts places 'Revenue- Communications, Media and Technology' at $802.35 million. The estimate indicates a year-over-year change of +2.2%.
The consensus among analysts is that 'Revenue- Products and Resources' will reach $1.14 billion. The estimate points to a change of +1.7% from the year-ago quarter.
Analysts predict that the 'Revenue- Health Sciences' will reach $1.39 billion. The estimate indicates a year-over-year change of -2.9%.
Shares of Cognizant have demonstrated returns of -8.7% over the past month compared to the Zacks S&P 500 composite's -2% change. With a Zacks Rank #4 (Sell), CTSH is expected to lag the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Countdown to Cognizant (CTSH) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS
Wall Street analysts expect Cognizant (CTSH - Free Report) to post quarterly earnings of $1.11 per share in its upcoming report, which indicates no change from the year-ago quarter. Revenues are expected to be $4.72 billion, down 1.9% from the year-ago quarter.
The current level reflects a downward revision of 0.3% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
Bearing this in mind, let's now explore the average estimates of specific Cognizant metrics that are commonly monitored and projected by Wall Street analysts.
The combined assessment of analysts suggests that 'Revenue- Financial services' will likely reach $1.38 billion. The estimate indicates a year-over-year change of -6.8%.
The average prediction of analysts places 'Revenue- Communications, Media and Technology' at $802.35 million. The estimate indicates a year-over-year change of +2.2%.
The consensus among analysts is that 'Revenue- Products and Resources' will reach $1.14 billion. The estimate points to a change of +1.7% from the year-ago quarter.
Analysts predict that the 'Revenue- Health Sciences' will reach $1.39 billion. The estimate indicates a year-over-year change of -2.9%.
View all Key Company Metrics for Cognizant here>>>
Shares of Cognizant have demonstrated returns of -8.7% over the past month compared to the Zacks S&P 500 composite's -2% change. With a Zacks Rank #4 (Sell), CTSH is expected to lag the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>